We are live on ! Find out more
GDRX icon

GoodRx Holdings
GDRX

180 hedge funds and large institutions have $651M invested in GoodRx Holdings in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 46 increasing their positions, 55 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 34

3% more funds holding

Funds holding: 174 → 180 (+6)

4% more call options, than puts

Call options by funds: $5.64M | Put options by funds: $5.44M

16% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 55

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

21.58% less ownership

Funds ownership: 186.97% → 165.4% (-22%)

29% less capital invested

Capital invested by funds: $916M → $651M (-$265M)

Holders
180
Holders Change
+6
Holders Change %
+3.45%
% of All Funds
3.1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
40
Increased
46
Reduced
55
Closed
34
Calls
$5.64M
Puts
$5.44M
Net Calls
+$204K
Net Calls Change
+$274K

Top Buyers

1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$9.12M
2
NIP
Norwood Investment Partners
California
+$7.53M
3
Voloridge Investment Management
Voloridge Investment Management
Florida
+$5.09M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.66M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$2.64M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$111M
2
Renaissance Technologies
Renaissance Technologies
New York
-$6.46M
3
GH
GAM Holding
Switzerland
-$5.09M
4
Bank of America
Bank of America
North Carolina
-$3.75M
5
EGM
Engineers Gate Manager
New York
-$3.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
FPM
1
Francisco Partners Management
California
$396M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$36.6M +$4.66M +739,017 +10%
LSCM
3
Light Street Capital Management
California
$19.6M -$2.76M -437,404 -9%
Marshall Wace
4
Marshall Wace
United Kingdom
$16.9M +$348K +55,218 +2%
SLG
5
Silver Lake Group
California
$16.5M – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$10.4M -$6.46M -1,024,000 -32%
PTC
7
Petrus Trust Company
Texas
$10.1M +$2.27M +359,632 +20%
Millennium Management
8
Millennium Management
New York
$9.88M +$2.44M +387,537 +22%
BlackRock
9
BlackRock
New York
$8.41M +$1.57M +248,593 +16%
TCMX
10
Technology Crossover Management X
California
$7.72M – – –
Two Sigma Investments
11
Two Sigma Investments
New York
$7.4M -$148K -23,410 -1%
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$6.75M +$9.12M +1,446,203 New
Two Sigma Advisers
13
Two Sigma Advisers
New York
$6.43M -$363K -57,600 -4%
Morgan Stanley
14
Morgan Stanley
New York
$6M -$111M -17,572,096 -93%
Voloridge Investment Management
15
Voloridge Investment Management
Florida
$5.72M +$5.09M +806,904 +193%
NIP
16
Norwood Investment Partners
California
$5.7M +$7.53M +1,194,742 +4,550%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$4.44M -$864K -137,008 -13%
Goldman Sachs
18
Goldman Sachs
New York
$4.13M +$2.26M +358,562 +68%
Schroder Investment Management Group
19
Schroder Investment Management Group
United Kingdom
$3.77M +$1.76M +278,555 +53%
Manulife (Manufacturers Life Insurance)
20
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.43M +$2.22M +352,110 +92%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$3.21M +$176K +27,904 +4%
LOAMS
22
Lombard Odier Asset Management (Switzerland)
Switzerland
$3.01M -$2.29M -362,849 -36%
Bank of America
23
Bank of America
North Carolina
$2.91M -$3.75M -594,271 -49%
RRCP
24
Rip Road Capital Partners
Massachusetts
$2.74M -$677K -107,420 -15%
Assenagon Asset Management
25
Assenagon Asset Management
Luxembourg
$2.72M +$155K +24,595 +4%
1
2 3 4 5

GDRX Hedge Fund Activity: Q3 2022 in Review

180 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2022, worth a combined $651M — down 29% from $916M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new GDRX positions and 34 closed out — a net gain of 6 holders — while 46 added to existing stakes and 55 trimmed.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $9.12M. The largest seller was Morgan Stanley, cutting an estimated $111M.

  • 180 institutional investors held GoodRx Holdings (GDRX) as of Q3 2022, up from 174 in Q2 2022.
  • Funds reported $651M of GoodRx Holdings stock for Q3 2022, down 29% quarter-over-quarter.
  • 40 funds opened new GoodRx Holdings positions in Q3 2022 and 34 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q3 2022 was Jacobs Levy Equity Management, an estimated $9.12M added.
  • The largest GoodRx Holdings seller in Q3 2022 was Morgan Stanley, an estimated $111M sold.

Based on aggregated 13F filings for Q3 2022.